Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Kura Oncology Inc.

    NASDAQ: KURA · Real-Time Price · USD
    6.48
    0.04 (0.62%)
    At close: Jun 16, 2025, 3:59 PM
    6.51
    0.46%
    After-hours: Jun 16, 2025, 05:39 PM EDT

    Kura Oncology Statistics

    Share Statistics

    Kura Oncology has 86.57M shares outstanding. The number of shares has increased by 6% in one year.

    Shares Outstanding

    n/a
    		 86.57M

    Shares Change (YoY)

    n/a
    		 6%

    Shares Change (QoQ)

    n/a
    		 3.85%

    Owned by Institutions (%)

    n/a
    		 90.8%

    Shares Floating

    n/a
    		 82.28M

    Failed to Deliver (FTD) Shares

    n/a
    		 43

    FTD / Avg. Volume

    n/a
    		 n/a

    Short Selling Information

    The latest short interest is 8.36M, so 10.35% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 8.36M

    Short % of Shares Out

    n/a
    		 10.35%

    Short % of Float

    n/a
    		 10.37%

    Short Ratio (days to cover)

    n/a
    		 6.89

    Valuation Ratios

    The PE ratio is -4.31 and the forward PE ratio is -3.35. Kura Oncology's PEG ratio is 1.5.

    PE Ratio

    n/a
    		 -4.31

    Forward PE

    n/a
    		 -3.35

    PS Ratio

    n/a
    		 13.93

    Forward PS

    n/a
    		 0.7

    PB Ratio

    n/a
    		 1.81

    P/FCF Ratio

    n/a
    		 5.61

    PEG Ratio

    n/a
    		 1.5
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Kura Oncology.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 9.46, with a Debt / Equity ratio of 0.04.

    Current Ratio

    n/a
    		 9.46

    Quick Ratio

    n/a
    		 9.46

    Debt / Equity

    n/a
    		 0.04

    Debt / EBITDA

    n/a
    		 -0.1

    Debt / FCF

    n/a
    		 0.12

    Interest Coverage

    n/a
    		 -119.33

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $280,640.62

    Profits Per Employee

    n/a
    		 $-906,161.46

    Employee Count

    n/a
    		 192

    Asset Turnover

    n/a
    		 0.07

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 2.02M

    Effective Tax Rate

    n/a
    		 -1.17%

    Stock Price Statistics

    The stock price has increased by -68.68% in the last 52 weeks. The beta is 0.4, so Kura Oncology's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.4

    52-Week Price Change

    n/a
    		 -68.68%

    50-Day Moving Average

    n/a
    		 6.16

    200-Day Moving Average

    n/a
    		 10.89

    Relative Strength Index (RSI)

    n/a
    		 53.05

    Average Volume (20 Days)

    n/a
    		 1,284,174

    Income Statement

    In the last 12 months, Kura Oncology had revenue of 53.88M and earned -173.98M in profits. Earnings per share was -2.02.

    Revenue

    n/a
    		 53.88M

    Gross Profit

    n/a
    		 53.03M

    Operating Income

    n/a
    		 -193.19M

    Net Income

    n/a
    		 -173.98M

    EBITDA

    n/a
    		 -169.5M

    EBIT

    n/a
    		 -170.35M

    Earnings Per Share (EPS)

    n/a
    		 -2.02
    Full Income Statement

    Balance Sheet

    The company has 224.46M in cash and 16.59M in debt, giving a net cash position of 207.87M.

    Cash & Cash Equivalents

    n/a
    		 224.46M

    Total Debt

    n/a
    		 16.59M

    Net Cash

    n/a
    		 207.87M

    Retained Earnings

    n/a
    		 -895.42M

    Total Assets

    n/a
    		 743.76M

    Working Capital

    n/a
    		 634.43M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 134.32M and capital expenditures -472K, giving a free cash flow of 133.84M.

    Operating Cash Flow

    n/a
    		 134.32M

    Capital Expenditures

    n/a
    		 -472K

    Free Cash Flow

    n/a
    		 133.84M

    FCF Per Share

    n/a
    		 1.55
    Full Cash Flow Statement

    Margins

    Gross margin is 98.43%, with operating and profit margins of -358.55% and -322.89%.

    Gross Margin

    n/a
    		 98.43%

    Operating Margin

    n/a
    		 -358.55%

    Pretax Margin

    n/a
    		 -319.15%

    Profit Margin

    n/a
    		 -322.89%

    EBITDA Margin

    n/a
    		 -314.57%

    EBIT Margin

    n/a
    		 -358.55%

    FCF Margin

    n/a
    		 248.4%

    Dividends & Yields

    KURA does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for KURA is $28, which is 332.1% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $28

    Price Target Difference

    n/a
    		 332.1%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 12
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -0.72

    Piotroski F-Score

    n/a
    		 5

    Add to Watchlist